Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
304,176
-
Shares change
-
+60,497
-
Total reported value, excl. options
-
$303,734
-
Value change
-
+$61,202
-
Number of buys
-
9
-
Number of sells
-
6
-
Price
-
$1.00
Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q1 2025
As of 31 Mar 2025 Hoth Therapeutics, Inc. - COM NEW (HOTH) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 304,176 shares of stock of the company.
Largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, Foundations Investment Advisors, LLC, HRT FINANCIAL LP, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, and OSAIC HOLDINGS, INC..
This table shows 16 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.